StonvexLoading…
StonvexStonvexStonvexCore line items from CHRD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.88B | $5.25B | $3.90B | $3.65B |
Operating Income | $197.43M | $1.10B | $1.27B | $1.58B |
Net Income | $44.46M | $848.63M | $1.02B | $1.86B |
EPS (Diluted) | $0.74 | $16.02 | $23.51 | $57.55 |
Total Assets | $13.07B | $13.03B | $6.93B | $6.63B |
Total Liabilities | $4.99B | $4.33B | $1.85B | $1.95B |
Cash & Equivalents | $189.53M | $36.95M | $318.00M | $593.15M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 56.76M | 60.07M | 41.25M | 41.48M |